A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies

about

Systems Based Study of the Therapeutic Potential of Small Charged Molecules for the Inhibition of IL-1 Mediated Cartilage Degradation IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates

P2860

Q36224923-F29E428E-526A-46EA-9625-90183C0FB81A Q58115475-7BE54407-7F25-41DB-8379-070DE9A2D1CC

P2860

A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies

Item

http://www.wikidata.org/entity/Q35921934

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies

@ast

A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies

@en

type

Item

label

A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies

@ast

A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies

@en

prefLabel

A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies

@ast

A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies

@en

P1476

A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies

@en

P2093

Boris Shulgin

http://www.w3.org/2001/XMLSchema#string

Gabriel Helmlinger

http://www.w3.org/2001/XMLSchema#string

Yuri Kosinsky

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system

IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25

IL-2 complex treatment can protect naive mice from bacterial and viral infection.

Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}

Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation.

Mechanistic model of natural killer cell proliferative response to IL-15 receptor stimulation

Selective enhancement of the tumour necrotic activity of TNF alpha with monoclonal antibody

Interaction affinity between cytokine receptor components on the cell surface.

Potential use of IL-2/anti-IL-2 antibody immune complexes for the treatment of cancer and autoimmune disease.

IL-7/anti-IL-7 mAb complexes augment cytokine potency in mice through association with IgG-Fc and by competition with IL-7R

P304

e0149154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0149154

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

294258052

http://www.w3.org/2001/XMLSchema#string

P698

26870966

http://www.w3.org/2001/XMLSchema#string

P932

4752257

http://www.w3.org/2001/XMLSchema#string

A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies

about

P2860

P2860

A Generic Mechanism for Enhanced Cytokine Signaling via Cytokine-Neutralizing Antibodies

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932